PLAU and esophageal squamous cell carcinoma: These effects are supported also in different studies by Lingling Fang et.al., and Yong P Hwang et.al., who showed that metformin inhibited uPA and MMP-9 in esophageal squamous cell carcinoma and human fibrosarcoma HT-1080 cells [68, 69].